Acute Decompensated Heart Failure Update

ISSN: 1875-6557 (Online)
ISSN: 1573-403X (Print)


Volume 10, 4 Issues, 2014


Download PDF Flyer




Current Cardiology Reviews

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Fei Lu
University of Minnesota Medical School
Minneapolis, MN 55455
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Acute Decompensated Heart Failure Update

Author(s): John R. Teerlink, Khalid Alburikan, Marco Metra and Jo E. Rodgers

Affiliation: Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, CB# 7569, Chapel Hill, NC 27599

Abstract

Acute decompensated heart failure (ADHF) continues to increase in prevalence and is associated with substantial mortality and morbidity including frequent hospitalizations. The American Heart Association is predicting that more than eight million Americans will have heart failure by 2030 and that the total direct costs associated with the disease will rise from $21 billion in 2012 to $70 billion in 2030.The increase in the prevalence and cost of HF is primarily the result of shifting demographics and a growing population. Although many large, randomized, controlled clinical trials have been conducted in patients with chronic heart failure, it was not until recently that a growing number of studies began to address the management of ADHF. It is the intent of this review to update the clinician regarding the evaluation and optimal management of ADHF

Keywords: Acute decompensated heart failure, diuretics, inotropes, vasodilators

Purchase Online Rights and Permissions

  
  



Article Details

Volume: 9
First Page: 1
Last Page: 11
Page Count: 11
DOI: 10.2174/1573403X09666131117174414
Advertisement

Related Journals



Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science